Basiliximab ( —— )

产品货号. M36560 CAS No. 179045-86-4

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Basiliximab
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Basiliximab (CHI 621) 是一种重组嵌合鼠/人 IgG1 单克隆抗白细胞介素 2 受体 (interleukin-2 receptor) 抗体。Basiliximab 可用于肾移植研究。
产品描述

Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation.
体外实验

Basiliximab specifically inhibits T lymphocyte proliferation by binding to the IL-2Rα.Basiliximab binds only to activated lymphocytes and macrophages/monocytes. Basiliximab does not affect resting T lymphocytes that do not express IL-2Rα.
体内实验

Basiliximab (CHI 621) (0.07 mg/rat; i.v.; once) decreases total placental natural killer cells in reduced uterine perfusion pressure (RUPP) rats.Animal Model:Timed-pregnant Sprague Dawley (SD) rats, reduced uterine perfusion pressure (RUPP) rat model of placental ischemia Dosage:0.07 mg/rat Administration:IV infusion, once Result:Decreased total placental natural killer cells. Had no effect to lower MAP or improve pup weight and placental weight.
同义词

——
通路

Others
靶点

Other Targets
受体

Interleukin
研究领域

——
适应症

——

1. McKeage K, et al. Basiliximab: a review of its use as induction therapy in renal transplantation. BioDrugs. 2010 Feb 1;24(1):55-76.?

计算器

产品手册

关联产品

Epsilon-momfluorothr...

Epsilon-momfluorothrin 是一种合成的 I 型拟除虫菊酯杀虫剂，可以活化组成性雄甾烷受体 (constitutive androstane receptor (CAR))，可诱导大鼠中肿瘤的发生。
Polylysine

Polylysine
JI-101

JI-101是一种口服多激酶抑制剂，靶向血管内皮生长因子受体2型（VEGFR-2）、血小板衍生生长因子受体β（PDGFR-β）和肝配蛋白B型受体4（EphB4）。